Incidence and risk factors associated with seizures in cerebral amyloid angiopathy

Brin E Freund1, Sofia S Sanchez-Boluarte2, Karen Blackmon3

  • 1Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.

PubMed

Insights

Seizures occur in nearly 20% of cerebral amyloid angiopathy (CAA) patients, often presenting as the first symptom. Lobar intracranial hemorrhage, CAA with inflammation, and superficial siderosis are key risk factors for seizures in CAA.

Area of Science:

  • Neurology
  • Neuroscience
  • Cerebrovascular Diseases

Background:

  • Cerebral amyloid angiopathy (CAA) is a significant cause of intracranial hemorrhage (ICH).
  • Seizures are a known complication of ICH, but their incidence and risk factors in diverse CAA patient cohorts remain understudied.

Purpose of the Study:

  • To investigate the incidence and identify risk factors for seizures in a heterogeneous cohort of patients diagnosed with cerebral amyloid angiopathy (CAA).
  • To analyze clinical features and comorbidities associated with seizures in CAA patients.

Main Methods:

  • Retrospective study of 284 patients with CAA (defined by modified Boston criteria v2.0) at Mayo Clinic Florida (2015-2021).
  • Analysis of clinical features, including lobar ICH, cortical/convexity subarachnoid hemorrhage (cSAH), superficial siderosis, and CAA with inflammation (CAA-ri).
  • Univariate and multivariate analyses were performed to determine seizure risk factors.

Main Results:

  • 19.7% of CAA patients experienced seizures, with 37.5% of these seizures being the initial diagnostic feature.
  • Seizures were more frequent in females and associated with lobar ICH, cSAH, superficial siderosis, and CAA-ri.
  • Lobar ICH (OR 2.1), CAA-ri (OR 3.8), and superficial siderosis (OR 3.7) were independently linked to increased seizure risk after adjusting for age and sex.

Conclusions:

  • Seizures are a common occurrence in patients with cerebral amyloid angiopathy.
  • Lobar intracranial hemorrhage, CAA with inflammation, and superficial siderosis are independent predictors of seizures in CAA.
  • These findings can inform optimized clinical monitoring and management strategies for patients with CAA.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
230
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
451
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
11
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.6K